First Time Loading...

XBiotech Inc
NASDAQ:XBIT

Watchlist Manager
XBiotech Inc Logo
XBiotech Inc
NASDAQ:XBIT
Watchlist
Price: 7.67 USD -1.16% Market Closed
Updated: May 1, 2024
Section:
 

Wall Street
Price Targets

XBIT Price Targets Summary
XBiotech Inc

Wall Street analysts forecast XBIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XBIT is 18 USD .

XBIT Lowest Forecast
Wall Street Target
Not Available
XBIT Average Forecast
Wall Street Target
18 USD
135% Upside
XBIT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
18 USD
135% Upside
Highest
Price Target
Not Available
XBiotech Inc Competitors:
Price Targets
RXRX
Recursion Pharmaceuticals Inc
70% Upside
IPSC
Century Therapeutics Inc
420% Upside
T
TSBX
Turnstone Biologics Corp
410% Upside
NTRA
Natera Inc
11% Upside
RXRX
Recursion Pharmaceuticals Inc
70% Upside
IPSC
Century Therapeutics Inc
420% Upside
T
TSBX
Turnstone Biologics Corp
410% Upside
NTRA
Natera Inc
11% Upside
ARWR
Arrowhead Pharmaceuticals Inc
150% Upside
GILD
Gilead Sciences Inc
33% Upside
CDMO
Avid Bioservices Inc
64% Upside
PANACEABIO
Panacea Biotec Ltd
51% Downside

Revenue
Forecast

Revenue Estimate
XBiotech Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
XBiotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
XBiotech Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
XBIT intrinsic value, competitors valuation, and company profile.
DCF Valuation
XBIT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XBIT stock valuation using valuation multiples.
Wall Street Estimates
XBIT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XBIT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XBIT's stock price target?
Price Target
18 USD

According to Wall Street analysts, the average 1-year price target for XBIT is 18 USD .

ALPHA SPREAD
Join more than 133,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.